Manager TitleAgeSince
Chief Executive Officer 61 2012-10-09
Director of Finance/CFO 63 2022-01-31
Director TitleAgeSince
Director/Board Member 61 2012-10-09
Change 5-day change 1-year change 3-year change Capi.($)
-95.53%-.--% - - 602
+1.07%-3.49%-3.25%+12.87% 46.86B
+0.25%+1.65%+408.41%+629.49% 40.23B
-0.27%+4.45%+9.93%+66.92% 36.23B
+0.35%+0.87%+3.60%-8.81% 34.72B
+3.14%+1.02%+3.37%+38.15% 27.89B
-0.73%+11.84%+31.97%+143.53% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%+0.76%+8.50% 13.12B
-2.68%-2.49%-15.00%-31.68% 12.7B
Average -9.35%+0.83%+54.97%+107.37% 27.25B
Weighted average by Cap. +0.48%+0.91%+75.32%+136.64%
Logo Trinity Resources Inc.
Alzex Neuropharma Inc. is a biopharmaceutical company. The Company is engaged in research and development targeting treatments of brain diseases. It is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.
Employees
-